Moreover, tumors taken from pancreatic cancer patients demonstrate elevated pro-inflammatory gene and protein expression of IL-6, IL-1β, and COX-2, as well as increased expression of monocyte chemoattractants [9], [10], [11]. This evidence concerns the gene PTGS2 and familial pancreatic carcinoma.